NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 61 filers reported holding NEUBASE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $14 | -54.8% | 79,620 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $31 | -99.9% | 79,620 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $31,000 | -62.7% | 79,620 | 0.0% | 0.00% | -60.0% |
Q2 2022 | $83,000 | -44.3% | 79,620 | 0.0% | 0.01% | -37.5% |
Q1 2022 | $149,000 | +166.1% | 79,620 | +296.4% | 0.01% | +166.7% |
Q4 2021 | $56,000 | -22.2% | 20,088 | 0.0% | 0.00% | -25.0% |
Q3 2021 | $72,000 | -25.0% | 20,088 | 0.0% | 0.00% | -33.3% |
Q2 2021 | $96,000 | – | 20,088 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
CM Management, LLC | 450,000 | $178,000 | 0.20% |
Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |